Atlas Trials

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Clinical trial NCT01648699 · TERMINATED

Trial details

NCT number
NCT01648699
Sponsor
Janssen Pharmaceutica
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pain
Start date
2010-04-01
Primary completion
2010-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.